Autoantibodies against opioid or glutamate receptors are associated with changes in morphine reward and physical dependence in mice

Psychopharmacology

Volumn 197, Issue 4, 2008, Pages 535-548

  Capone, Francesca ^a   Adriani, Walter ^a   Shumilina, Maria ^b,c   Izykenova, Galina ^d   Granstrem, Oleg ^b,c   Dambinova, Svetlana ^d   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^c GEROPHARM Ltd   (Russian Federation)

^d EMORY UNIVERSITY   (United States)

Author keywords

Abstinence withdrawal; Autoantibodies to neuroreceptors; Behavior; GluR1 AMPA subunit; MDOR opioid receptor; Reward

Indexed keywords

AUTOANTIBODY; DELTA OPIATE RECEPTOR; GLUTAMATE RECEPTOR 1; MORPHINE; MU OPIATE RECEPTOR; NALOXONE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BRUXISM; CONTROLLED STUDY; DOWN REGULATION; DRUG DEPENDENCE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; EVENING DOSAGE; GROOMING; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REARING; SNIFFING; TREMOR;

ANIMALS; AROUSAL; AUTOANTIBODIES; AVOIDANCE LEARNING; BRAIN; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GROOMING; IMMUNIZATION; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; MOTIVATION; MOTOR ACTIVITY; NALOXONE; PEPTIDE FRAGMENTS; RECEPTORS, AMPA; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; REWARD; SOCIAL ENVIRONMENT; STEREOTYPED BEHAVIOR; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 41849135412     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-1062-y     Document Type: Article

References (83)

1. Adriani W, Laviola G (2002) Spontaneous novelty seeking and amphetamine-induced conditioning and sensitization in adult mice: evidence of dissociation as a function of age at weaning. Neuropsychopharmacology 27:225-236
2. Adriani W, Caprioli A, Granstrem O, Carli M, Laviola G (2003) The spontaneously hypertensive-rat as an animal model of ADHD: evidence for impulsive and non-impulsive subpopulations. Neurosci Biobehav Rev 27:639-651
3. Aghajanian GK (1978) Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276:186-188
4. Alleva E, Caprioli A, Laviola G (1986) Postnatal social environment affects morphine analgesia in male mice. Physiol Behav 36:779-781
5. Bailey CP, Connor M (2005) Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5:60-68
6. Berridge KC, Aldridge JW (2000) Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists. Synapse 37:194-204
7. Berridge KC, Aldridge JW, Houchard KR, Zhuang X (2005) Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a new model of obsessive compulsive disorder and Tourette's. BMC Biol 3:4
8. Burford NT, Tolbert LM, Sadee W (1998) Specific G protein activation and A-opioid receptor internalization caused by morphine, DAMGO and endomorphin-I. Eur J Pharmacol 342:123-126
9. Cachia PJ, Kao DJ, Hodges RS (2004) Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross-reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy. J Mol Recognit 17:540-557
10. Capone F, Puopolo M, Branchi I, Alleva E (2002) A new easy accessible and low-cost method for screening olfactory sensitivity in mice: behavioural and nociceptive response in male and female CD-1 mice upon exposure to millipede aversive odour. Brain Res Bull 58:193-202
11. Carlezon WA Jr, Nestler EJ (2002) Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci 25:610-615
12. Carlezon WA Jr., Rasmussen K, Nestler EJ (1999) AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine. Synapse 31:256-262
13. Cohen-Kashi-Malina K, Ganor Y, Levite M, Teichberg VI (2006) Auto-antibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels. Neurochem Res 31:1181-1190
14. Cunha-Oliveira T, Rego AC, Garrido J, Borges F, Macedo T, Oliveira CR (2007) Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons. J Neurochem 101(2):543-544 Jan 22 [Epub ahead of print]
15. Dafny N, Pellis NR (1986) Evidence that opiate addiction is in part an immune response. Destruction of the immune system by irradiation-altered opiate withdrawal. Neuropharmacology 25:815-818
16. Dambinova SA, Izykenova GA (2002) Recombinant mu-delta receptor as a marker of opiate abuse. Ann N Y Acad Sci 965:497-514
17. Dambinova SA, Izykenova GA, Burov SV, Grigorenko EV, Gromov SA (1997) The presence of autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptor in the blood serum of patients with epilepsy. J Neurol Sci 152:93-97
18. Dambinova SA, Granstrem OK, Tourov A, Salluzzo R, Castello F, Izykenova GA (1998) Monitoring brain spiking activity and autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptors in blood serum of rats with cobalt-induced epilepsy. J Neurochem 71:2088-2093
19. Dambinova SA, Khounteev GA, Izykenova GA, Zavolokov IG, Ilyukhina AY, Skoromets AA (2003) Blood test detecting autoantibodies to NMDA neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem 49:1752-1762
20. Dell'Omo G, Vannoni E, Vyssotski AL, Di Bari MA, Nonno R, Agrimi U et al (2002) Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences. Eur J Neurosci 16:735-742
21. Deroche-Gamonet V, Belin D, Piazza PV (2004) Evidence for addiction-like behavior in the rat. Science 305:1014-1017
22. Devine DP, Wise RA (1994) Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci 14:1978-1984
23. Di Chiara G, North RA (1992) Neurobiology of opiate abuse. Trends Pharmacol Sci 13:185-193
24. Dougherty PM, Pellis NR, Dafny N (1990) The brain and the immune system: an intact immune system is essential for the manifestation of withdrawal in opiate addicted rats. Neuroscience 36:285-289
25. During MJ, Symes CW, Lawlor PA, Lin J, Dunning J, Fitzsimons HL, Poulsen D, Leone P, Xu R, Dicker BL, Lipski J, Young D (2000) An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 287:1453-1460
26. Ettenberg A, Pettit HO, Bloom FE, Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology (Berl) 78:204-209
27. Ganor Y, Teichberg VI, Levite M (2007) TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage. J Immunol 178:683-692
28. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA (2000) Heterodimerization of mu and delta opioid receptors A role in opiate synergy. J Neurosci 20:RC110
29. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA (2004) A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101:5135-5139
30. Granstrem OK, Adriani W, Shumilina M, Izykenova GA, Dambinova SA, Laviola G (2006) Specific changes in levels of autoantibodies to glutamate and opiate receptors induced by morphine administration in rats. Neurosci Lett 403:1-5
31. Granstrem OK, van Rijn T, Voskuyl RA, Dambinova SA (1997) Autoantibodies to a fragment of AMPA/quisqualate glutamate receptor in rat model of epilepsy. Neyrokhimija 14:75-87
32. He S, Grasing K (2004) Chronic opiate treatment enhances both cocaine-reinforced and cocaine-seeking behaviors following opiate withdrawal. Drug Alcohol Depend 75:215-221
33. Horner KA, Zadina JE (2004) Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells. Brain Res 1028:121-132
34. Hyman SE, Malenka RC (2001) Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2:695-703
35. Izykenova GA, Sirenko VV, Dambinova SA (1995) Immunodiagnostics of drug addiction. J Problems Drug Abuse 1:45-49
36. Jackson A, Mead AN, Stephens DN (2000) Behavioural effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to the substance abuse. Pharmacol Ther 88:59-76
37. James IF, Goldstein A (1984) Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. Mol Pharmacol 25:337-342
38. Johnson SM, Fleming WW (1989) Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. Pharmacol Rev 41:435-488
39. Kalueff AV, Tuohimaa P (2004) Contrasting grooming phenotypes in C57Bl/6 and 129S1/SvImJ mice. Brain Res 1028:75-82
40. Kalueff AV, Tuohimaa P (2005) Contrasting grooming phenotypes in three mouse strains markedly different in anxiety and activity (129S1, BALB/c and NMRI). Behav Brain Res 160:1-10
41. Knight JG, Menkes DB, Highton J, Adams DD (2007) Rationale for a trial of immunosuppressive therapy in acute schizophrenia. Mol Psychiatry 12(5):424-431 Jan 23 [Epub ahead of print]
42. Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 103:19854-19859
43. Kreek MJ (2001) Drug addictions. Molecular and cellular endpoints. Ann N Y Acad Sci 937:27-49
44. Levite M, Fleidervish IA, Schwarz A, Pelled D, Futerman AH (1999) Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J Autoimmun 13:61-72
45. Lord JA, Waterfield AA, Hughes J, Kosterlitz HW (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature 267:495-499
46. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borrelli E (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388:586-589
47. Malenka RC (2003) Synaptic plasticity and AMPA receptor trafficking. Ann N Y Acad Sci 1003:1-11
48. Martin TJ, Dworkin SI, Smith JE (1995) Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats. J Pharmacol Exp Ther 272:1135-1140
49. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I et al (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383:819-823
50. McLemore GL, Kest B, Inturrisi CE (1997) The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence. Brain Res 778:120-126
51. Mosberg HI, Hurst R, Hruby VJ, Gee K, Yamamura HI, Galligan JJ et al (1983) Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Nat Acad Sci U S A 80:5871-5874
52. Nazzaro JM, Seeger TF, Gardner EL (1981) Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds. Pharmacol Biochem Behav 14:325-331
53. Nestler EJ (2001) Molecular neurobiology of addiction. Am J Addict 10:201-217
54. Nieto MM, Wilson J, Cupo A, Roques BP, Noble F (2002) Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study. J Neurosci 22:1034-1041
55. Noda M, Nakanishi H, Nabekura J, Akaike N (2000) AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 20:251-258
56. Noldus LP (1991) Observer, a software system for collection and analysis of data. Behav Res Methods Instrum Comput 23:415-429
57. Park Y, Ho IK, Fan LW, Loh HH, Ko KH (2001) Region specific increase of dopamine receptor D1/D2 mRNA expression in the brain of mu-opioid receptor knockout mice. Brain Res 894:311-315
58. Paterson SJ, Robson LE, Kosterlitz HW (1983) Classification of opioid receptors. Br Med Bull 39:31-36
59. Pettit HO, Ettenberg A, Bloom FE, Koob GF (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) 84:167-173
60. Piazza PV, Deminiere JM, Le Moal M, Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511-1513
61. Porreca F, Burks TF (1993) Supraspinal opioid receptors in antinociception. In: Herz A (ed) Opioids II-handbook of experimental pharmacology. Springer, Berlin, pp 21-52
62. Rasmussen K, Kendrick WT, Kogan JH, Aghajanian GK (1996) A selective AMPA antagonist, LY-293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology 15:497-505
63. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265:648-651
64. Roy BF, Bowen WD, Frazier JS, Rose JW, McFarland HF, McFarlin DE, Murphy DL, Morihisa JM (1988) Human anti-idiotypic antibody against opiate receptors. Ann Neurol 24:57-63
65. Sanchez-Blazquez P, Rodriguez MD, Garzon J (1996) Antibodies directed against the mu-opioid receptor alleviated multiple signs of morphine withdrawal in mice. Life Sci 59:PL87-PL92
66. Sanchez-Blazquez P, Garcia-Espana A, Garzon J (1997) Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors. J Pharmacol Exp Ther 280:1423-1431
67. Sharma HS, Ali SF (2006) Alterations in blood-brain barrier function by morphine and methamphetamine. Ann NY Acad Sci 1074:198-224
68. Siggins GR, Martin G, Roberto M, Nie Z, Madamba S, De Lecea L (2003) Glutamatergic transmission in opiate and alcohol dependence. Ann NY Acad Sci 1003:196-211
69. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM et al (1997) Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci USA 94:1544-1549
70. Sora I, Elmer G, Funada M, Pieper J, Li XF, Hall FS et al (2001) Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve. Neuropsychopharmacology 25:41-54
71. Stevens KE, Mickley GA, McDermott LJ (1986) Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57B1/6J mouse. Pharmacol Biochem Behav 24:1739-1747
72. Twyman RE, Gahring LC, Spiess J, Rogers SW (1995) Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 14:755-762
73. Tzschentke TM, Schmidt WJ (1997) Interactions of MK-801 and GYKI 52466 with morphine and with amphetamine in place preference conditioning and behavioural sensitization. Behav Brain Res 84:99-107
74. Vanderschuren LJ, Everitt BJ (2004) Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305:1017-1019
75. van Wolfswinkel L, Seifert WF, van Ree JM (1985) Long-term changes in self-stimulation threshold by repeated morphine and naloxone treatment. Life Sci 37:169-176
76. Vekovischeva OY, Zamanillo D, Echenko O, Seppala T, Uusi-Oukari M, Honkanen A et al (2001) Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits. J Neurosci 21:4451-4459
77. Vincent A, Lily O, Palace J (1999) Pathogenic autoantibodies to neuronal proteins in neurological disorders. J Neuroimmunol 100:169-180
78. Wang L, Cheng H (2005) Immune function of microglia. Mianyixue Fence 28:37-40
79. Wise RA (1996) Neurobiology of addiction. Curr Opin Neurobiol 6:243-251
80. Woods JH, Winger G (1987) Opioids, receptors and abuse liability. In: Melter HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 1555-1579
81. World Health Report (2002) World Health Organization, Geneva, Switzerland
82. Zandman-Goddard G, Chapman J, Shoenfeld Y (2007) Autoantibodies involved in neuro-psychiatric SLE and anti-phospholipid syndrome. Semin Arthritis Rheum 36(5):297-315 Jan 25 [Epub ahead of print]
83. Zhu H, Rockhold RW, Ho IK (1998) The role of glutamate in physical dependence on opioids. Japan J Pharmacol 76:1-14